comparemela.com

Latest Breaking News On - Carles dom - Page 1 : comparemela.com

AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812

AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients. 

Spain
France
Israel
Canada
Canadian
Svetoslava-georgieva
Carles-dom
Shermaine-tilley
Sara-secall
Spain-ministry-of-science
Life-sciences
Ability-pharmaceuticals

AbilityPharma Announces ? 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer

AbilityPharma Announces ? 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Luxembourg
Montreal
Quebec
Canada
Israel
France
Barcelona
Comunidad-autonoma-de-cataluna
Spain
United-states
Canadian
Svetoslava-georgieva

AbilityPharma Raises €7M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Spain
United-states
France
Barcelona
Comunidad-autonoma-de-cataluna
Israel
Carles-dom
Life-sciences-fund
Ability-pharmaceuticals
Sciences-fund

Illicit centipede raises thorny question: Should journals have refused to publish a paper about it?

In 2018, a new species of centipede graced the pages of the prominent taxonomy journal Zootaxa. More than 14 centimeters long, with striking teal-colored legs, it lives in the montane and mossy forests of the Philippines. Now, however, the centipede is in a harsh spotlight. The Philippine government says the Spanish neurologist and amateur biologist who described the species acquired his specimens illegally. Neither the journal’s editors nor its peer reviewers caught the lapse and the journal has no policy requiring documentation that specimens have been collected with proper permits. Some editors tell  Science that should change. Others worry about hampering research when undescribed species are vanishing fast. And all agree that journals would struggle to enforce any such rules, given the wide variation in countries’ legal requirements. “There is simply no way for a journal to police this,” says Maarten Christenhusz, an independent botanist and editor-in-chief of the

Nagoya
Aichi
Japan
Philippines
Philippine
Benguet
New-zealand
Paris
France-general
France
Finland
California

vimarsana © 2020. All Rights Reserved.